Botanical species · safety record

Solidago gigantea

The EFSA Compendium of Botanicals holds 9 constituent measurements for Solidago gigantea. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Solidago gigantea Aiton

9Constituent measurements

0Safety records

6Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Clerodane-type diterpenes	Seed	Solvent extraction	—	GC-MS	Resolve DOI
Furan derivatives	Seed	Solvent extraction	—	GC-MS	Resolve DOI
Myrcene	Seed	Solvent extraction	—	GC-MS	Resolve DOI
Myrcene	Aerial part of plants	Essential oil	2.6 Percent	GC-MS	Resolve DOI
Saponins	Roots and other underground parts	Solvent extraction	≤ 1.9 Percent	HPLC with standard detection methods	Resolve DOI
Saponins	Roots and other underground parts	Solvent extraction	≥ 0.8 Percent	HPLC with standard detection methods	Resolve DOI
Pentacyclic triterpene saponins	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Pentacyclic triterpene saponins	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Pentacyclic triterpene saponins	Aerial part of plants	Solvent extraction	—	Unspecified	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Johnson, Robert H., Hull-Sanders, Helen M., Meyer, Gretchen A. Comparison of foliar terpenes between native and invasive Solidago gigantea. BIOCHEMICAL SYSTEMATICS AND ECOLOGY, 2007, vol. 35, no. 12, p. 821-830. DOI
REZNICEK, G., JURENITSCH, J., KUBELKA, W., MICHL, G., KORHAMMER, S., HASLINGER, E. ISOLATION AND STRUCTURE OF THE 4 MAIN SAPONINS FROM SOLIDAGO-GIGANTEA VAR SEROTINA . Liebigs annalen der chemie, 1990, no. 10, p. 989-994.
Reznicek, G., Jurenitsch, J., Michl, G., Haslinger, E. The first structurally confirmed saponin from Solidago gigantea: structure elucidation by modern NMR techniques. Tetrahedron Letters, 1989, p. 4097-4100.
Kalemba, D., Marschall, H., Bradesi, P. Constituents of the essential oil of Solidago gigantea Ait. (giant goldenrod). FLAVOUR AND FRAGRANCE JOURNAL, 2001, vol. 16, no. 1, p. 19-26. DOI
Reznicek, G., Freiler, M., Schader, M., Schmidt, U. Determination of the content and the composition of the main saponins from Solidago gigantea AIT. Using high-performance liquid chromatography. JOURNAL OF CHROMATOGRAPHY A, 1996, vol. 755, no. 1, p. 133-137. DOI
Hiller, K., Bader, G., Reznicek, G., Jurenitsch, J., Kubelka, W. The main saponins of medicinally used species of the genus Solidago. Pharmazie, 1991, p. 405-408.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature